Cytokinetics CYTK Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's total assets?
- Cytokinetics (CYTK) reported total assets of $1.27B in Q1 2026.
- How has Cytokinetics's total assets changed year-over-year?
- Cytokinetics's total assets increased by 0.7% year-over-year, from $1.26B to $1.27B.
- What is the long-term trend for Cytokinetics's total assets?
- Over 5 years (2020 to 2025), Cytokinetics's total assets has grown at a 21.7% compound annual growth rate (CAGR), from $533.8M to $1.42B.
- What does total assets mean?
- The total value of everything the company owns.
- How do you interpret total assets?
- An increase generally reflects company growth, capital investment, or successful fundraising, while a decrease may indicate asset impairment or cash burn.
- How does total assets compare across companies?
- Used to compare the scale of operations across the biotech sector; larger asset bases often correlate with more advanced clinical pipelines.